|
ARSK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.01350000006428E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.78700000000354E-05 |
| Normal-vs-Stage2 |
9.764700E-04 |
| Normal-vs-Stage3 |
2.28130000445859E-08 |
| Normal-vs-Stage4 |
6.10820000024326E-07 |
| Stage1-vs-Stage2 |
7.057200E-01 |
| Stage1-vs-Stage3 |
1.217950E-02 |
| Stage1-vs-Stage4 |
7.179900E-02 |
| Stage2-vs-Stage3 |
1.711000E-01 |
| Stage2-vs-Stage4 |
3.169400E-01 |
| Stage3-vs-Stage4 |
7.148400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.9258000000244E-06 |
| Normal-vs-AfricanAmerican |
2.91809998387293E-09 |
| Normal-vs-Asian |
1.430780E-01 |
| Caucasian-vs-AfricanAmerican |
8.478100E-03 |
| Caucasian-vs-Asian |
7.665400E-01 |
| AfricanAmerican-vs-Asian |
1.272950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.36210000004178E-07 |
| Normal-vs-Female |
3.74400000002773E-06 |
| Male-vs-Female |
5.245000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.72779999985507E-07 |
| Normal-vs-Age(41-60Yrs) |
1.60128999999731E-05 |
| Normal-vs-Age(61-80Yrs) |
3.98379999988485E-07 |
| Normal-vs-Age(81-100Yrs) |
3.853900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.743900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.047800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.910000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.182800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.926800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.112000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.134200E-02 |
| Normal-vs-Grade 2 |
6.641100E-04 |
| Normal-vs-Grade 3 |
6.99910018830963E-10 |
| Normal-vs-Grade 4 |
3.38929995180592E-09 |
| Grade 1-vs-Grade 2 |
8.738000E-01 |
| Grade 1-vs-Grade 3 |
3.013400E-01 |
| Grade 1-vs-Grade 4 |
9.134200E-02 |
| Grade 2-vs-Grade 3 |
5.484200E-03 |
| Grade 2-vs-Grade 4 |
3.412700E-04 |
| Grade 3-vs-Grade 4 |
6.231500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.539000E-03 |
| Normal-vs-ccB subtype |
1.1470999705665E-09 |
| ccA subtype-vs-ccB subtype |
7.85040000000903E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67619999991153E-07 |
| Normal-vs-N1 |
8.39790000000118E-05 |
| N0-vs-N1 |
1.317030E-01 |
|
|
